Pfizer's Weight-Loss Data Just Upends Investor Bets
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
An overview of how weight decay factors into index performance and the practical implications for index-following strategies.
28,062 articlesPfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Thinking ahead to 2026? This guide explains why a Vanguard index fund before the next big move can fit a simple, disc...
A disciplined plan using leveraged ETFs can magnify gains in strong markets, but path dependence and decay risk loom....
When the Fed signals a policy shift, traders rush to position. This article dives into the appeal of a 3X Financial B...
As GLP-1 therapies reshape obesity treatment, investors eye the best weight loss drug stock bets for 2026. This guide...
A rapid AI-driven capex cycle is widening the performance split between cap-weighted and equal-weight NASDAQ funds, u...
A new AI-driven supercycle is unfolding, but you don’t need to chase dramatic bets. This guide explains how agentic A...
Karman Holdings stock zoomed more than 6% today as the company was added to a major index. Here’s what happened, why ...
KORU, the 3X South Korea ETF, tumbles about 28% in a single week even as it posted massive prior gains. The selloff u...
A single-session drop in the 3X leveraged FNGU ETN trimmed a $10,000 bet to $8,392, illustrating how tech leverage ca...
A newly launched XRP ETF promises to deliver twice the daily moves of XRP, inviting traders to pursue a quick double ...
An equal-weight large-cap ETF is gaining attention as a retirement-friendly alternative to cap-weighted funds. Here’s...